Recent advances in cardio‐oncology: a report from the ‘Heart Failure Association 2019 and World Congress on Acute Heart Failure 2019’

Recent advances in cardio‐oncology: a report from the ‘Heart Failure Association 2019 and World Congress on Acute Heart Failure 2019’

Abstract While anti‐cancer therapies, including chemotherapy, immunotherapy, radiotherapy, and targeted therapy, are constantly advancing, cardiovascular toxicity has become a major challenge for cardiologists and oncologists. This has led to an increasing demand of cardio‐oncology units in Europe a...

Full description

Bibliographic Details
Main Authors: Markus S. Anker, Sara Hadzibegovic, Alessia Lena, Yury Belenkov, Jutta Bergler‐Klein, Rudolf A. deBoer, Dimitrios Farmakis, Stephan vonHaehling, Zaza Iakobishvili, Christoph Maack, Radek Pudil, Hadi Skouri, Alain Cohen‐Solal, Carlo G. Tocchetti, Andrew J.S. Coats, Petar M. Seferović, Alexander R. Lyon, for the Heart Failure Association Cardio‐Oncology Study Group of the European Society of Cardiology
Format: Article
Language:English
Published: Wiley 2019-12-01
Series:ESC Heart Failure
Subjects:
Cardiotoxicity
Heart failure
Cancer
Online Access:https://doi.org/10.1002/ehf2.12551

Internet

https://doi.org/10.1002/ehf2.12551

Similar Items